TRANSGENE BIOTEK LTD. - Board Meeting Outcome for Outcome Of Board Meeting.

1) The Board has considered and approved the unaudited Consolidated & Standalone Financial Results of the company, for the Quarter ended 31.12.2022 in accordance with the Indian Accounting Standards (IND-AS) as per Companies (Indian Accounting Standards) Rules, 2015. 2) Limited Review Report on the Unaudited Standalone and Consolidated Financial Results of the Company, for the quarter ended 31.12.2022 has also been approved.